These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10022538)

  • 1. Rewriting the "points to consider": the ethical impact of guidance document language.
    King NM
    Hum Gene Ther; 1999 Jan; 10(1):133-9. PubMed ID: 10022538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NIH "Points to Consider" and the limits of human gene therapy.
    Juengst ET
    Hum Gene Ther; 1990; 1(4):425-33. PubMed ID: 2078585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols.
    Scharschmidt T; Lo B
    Hum Gene Ther; 2006 Apr; 17(4):448-54. PubMed ID: 16610932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 7. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 8. NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee.
    O'Reilly M; Shipp A; Rosenthal E; Jambou R; Shih T; Montgomery M; Gargiulo L; Patterson A; Corrigan-Curay J
    Methods Enzymol; 2012; 507():313-35. PubMed ID: 22365781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gene therapy: ethics and public policy.
    Walters L
    Hum Gene Ther; 1991; 2(2):115-22. PubMed ID: 1911932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards.
    Burger IM; Wilfond BS
    Hum Gene Ther; 2000 May; 11(7):1057-63. PubMed ID: 10811234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 12. Points to consider in the design and submission of human somatic cell gene therapy protocols.
    Recomb DNA Tech Bull; 1985 Dec; 8(4):181-6. PubMed ID: 3912845
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1985 Dec; 8(4):176-80. PubMed ID: 3867980
    [No Abstract]   [Full Text] [Related]  

  • 14. The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.
    Anderson WF; Blaese RM; Culver K
    Hum Gene Ther; 1990; 1(3):331-62. PubMed ID: 11642817
    [No Abstract]   [Full Text] [Related]  

  • 15. The National Institutes of Health system for enhancing the science, safety, and ethics of recombinant DNA research.
    Shipp AC; Patterson AP
    Comp Med; 2003 Apr; 53(2):159-64. PubMed ID: 12784849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating ethical concerns in planned emergency research involving critically ill patients: an interpretation of the guidance document from the United States Food and Drug Administration.
    Smischney NJ; Onigkeit JA; Hinds RF; Nicholson WT
    J Clin Ethics; 2015; 26(1):61-7. PubMed ID: 25794295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH.
    Friedmann T; Noguchi P; Mickelson C
    Curr Opin Biotechnol; 2001 Jun; 12(3):304-7. PubMed ID: 11404110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 2000 May; 11(8):1211-29. PubMed ID: 11660775
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of NIHRAC focuses on gene therapy.
    Fox JL
    Biotechnology (N Y); 1995 May; 13(5):431-2. PubMed ID: 9634783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.